Latest / Chat with Greg Fridman
Plasma Bioengineering Myths
Bioengineering is full of oversimplifications.
In this episode, I break down common myths that show up in research papers, startups, and even academic labs:
• “More power = more effect”
• “In vitro results translate directly to patients”
• “Reactive species are always harmful”
• “If it works once, it scales”
• “Plasma is just oxidation”
We’ll talk about dose-response behavior, mechanistic rigor, nonlinear biology, scaling challenges, and why systems thinking matters.
I’ve spent over a decade as a research professor and now run an R&D company focused on plasma systems for medical and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.